The lack of precise clinical criteria for assessment of periodontal disease has led to a search for alternative means of determining active disease sites, prognosis of future sites of breakdown, and response to therapy. This review highlights the potential array of biomarkers present in gingival crevicular fluid and which may relate to existing or predicted tissue regions undergoing metabolic change and derived from bacterial or host-cell-derived products. Among the former may be listed endotoxin, amines, butyrate, and a variety of enzymes and their inhibitors, such as trypsin-like proteases and bacterial collagenase. Arising from host cells is a variety of leucocytic hydrolase enzymes, lactoferrin, and lysozyme. These appear to be useful inflammatory markers and may be distinguished from products of connective tissue breakdown which include collagenous and non-collagenous products, including collagen peptides, osteonectin, and fibronectin. The proteoglycans have found particular favor as biomarkers of possible bone-resorptive activity. Attention has also been directed at the immune response, including comment on immunoglobulins, complement, eicosanoids, and cytokines. This review lists available information on the presence of these in gingival sulcus fluid and wherever possible relates their presence to disease activity.
Get full access to this article
View all access options for this article.
References
1.
Adonogianaki E., Moughal NA, Kinane DF (1993). Lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal diseases. J Clin Periodontol20:26-31.
2.
Al-Bayaty H., Embery G., Waddington RJ (1991). Detection of polyclonal antibodies to alveolar bone chondroitin 4-sulphate proteoglycan (abstract). J Dent Res70:714.
3.
Baehni P., Sudan JM, Steube W., Cimasoni G. (1975). Enzymes lysosomiales dans les produits de rinçage de la region parodontale marginale au course de la gingivite expérimentale chez l'homme. J Biol Buccale3:143-156.
4.
Bartold PM (1987). Proteoglycans of the periodontium: structure, role and function. J Periodont Res22:431-444.
5.
Bartold PM, Wiebkin OW, Thonard JC (1981). Glycosaminoglycans of human gingival epithelium and connective tissues. Connect Tissue Res9:99-106.
6.
Beck CB, Embery G., Langley MS, Waddington RJ (1991). Levels of glycosaminoglycans in peri-implant sulcus fluid as a means of monitoring bone response to endosseous dental implants . Clin Oral Impl Res2:179-185.
7.
Bickel M., Cimasoni G., Andersen E. (1985). Flow and albumin content of (pre-inflammatory) gingival crevicular fluid from human subjects. Arch Oral Biol30:599-602.
8.
Bowers MA, Fisher LW, Termine JD, Somerman MJ (1989). Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal diseases. J Periodontol60:448-451.
9.
Brandtzaeg P. (1965). Immunochemical comparison of proteins in human gingival pocket fluid, serum and saliva. Arch Oral Biol10:795-803.
10.
Brandtzaeg P., Mann WV ( 1964). A comparative study of the lysozyme activity of human gingival pocket fluid, serum and saliva. Acta Odontol Scand22:441-445.
11.
Bricknell K., Grinenko V., Carlton D., Newman MG (1978). GLC rapid analysis of bacteria in plaque (abstract) . J Dent Res57:351.
12.
Carlton D., Bricknell K., Newman MG, Yoon N., Woolfe S., Horikoshi A. (1979). Comparison of chromatographic profiles of plaque from idiopathic juvenile periodontitis (abstract). J Dent Res58:177.
13.
Challacombe SJ, Russell MW, Hawkes JE, Bergmeier LA, LehnerT. (1978). Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology35 :923-931.
14.
Charon JA, LugerTA, Mergenhagen SE, OppenheimJJ (1982). Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun38:1190-1195.
15.
Cimasoni G. (1983). Crevicular fluid updated. In: Myers H, editor. Monographs in oral science. Vol. 12. Basel: Karger.
16.
Cimasoni G., Kowashi Y. (1980). Proteinases of the gingival crevice and their inhibitors. In: Lehner T, Cimasoni G, editors. Borderland between caries and periodontal disease. Vol. II. London: Academic Press, 31-49.
17.
Cox SW, Eley BM ( 1989a). Tryptase-like activity in crevicular fluid from gingivitis and periodontitis patients. J Periodont Res24:41-44.
18.
Cox SW, Eley BM ( 1989b). Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IVlike activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifluoromethylcoumarin . J Periodont Res24:353-361.
19.
Cox SW, Eley BM, Smith RE (1990). A simple, combined fluorogenic and chromogenic method for the assay of proteases in gingival crevicular fluid. J Periodont Res25:164-171.
20.
Curtis MA, Gillett IR, Griffiths GS, Maiden MFJ, Sterne JAC, Wilson DT, et al. (1989). Detection of high-risk individuals for periodontal diseases. Laboratory markers from analysis of gingival crevicular fluid. J Clin Periodont16:1-11.
21.
Ebersole JL, Holt SC ( 1991). Immunological procedures for diagnosis and risk assessment in periodontal diseases. In:
22.
Johnson NW, editor. Risk markers for oral diseases. Periodontal diseases; markers of disease susceptibility and activity. Vol. 3. Cambridge: Cambridge University Press, 203-227.
23.
Ebersole JL, Taubman MA, Smith DJ, Genco RJ, Frey DE ( 1982). Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to A. actinomycetemcomitans. Clin Exp Immunol47:43-52.
24.
Ebersole JL, Taubman MA, Smith DJ, Haffajee AD (1985). Effect of subgingival scaling on systemic antibody responses to oral microorganisms. Infect Immun48:534-539.
25.
Eley BM, Cox SW (1992). Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss . J Dentistry20:90-99.
26.
Embery G., Waddington RJ, Last KS ( 1991). The connective tissues of the periodontium and their breakdown products in gingival crevicular fluid as markers of periodontal disease susceptibility and activity. In: Johnson NW, editor. Risk markers for oral diseases. Periodontal diseases; markers of disease susceptibility and activity. Vol. 3. Cambridge: Cambridge University Press, 338-364.
27.
Friedman SA, Mandel ID, Herrera MS (1983). Lysozyme and lactoferrin quantitation in the crevicular fluid. J Periodont54:347-350.
28.
Golub LM, Siegal K., Ramamurthy NS, Mandel ID (1976). Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans . J Dent Res55:1049-1057.
29.
Griffiths GS (1992). Crevicular fluid markers in tissue damage. In: Newman HN, Williams DM, editors. Inflammation and immunology in chronic inflammatory periodontal disease. Proceedings of a symposium under the auspices of the British Inflammation Research Association . Northwood: Science Reviews Limited , 127-140.
30.
Haffajee AD, Socransky SS, Ebersole JL, Smith DJ (1984). Clinical, microbiological and immunological features associated with the treatment of periodontal lesions. J Clin Periodontol9:600-618.
31.
Hara K., Takahashi T. (1975). Hydroxyproline content in gingival exudate before and after periodontal surgery. J Periodont Res10:270-274.
32.
Hopps RM (1992). Mechanisms of bone resorption in chronic inflammatory periodontal disease. In: Newman HN, Williams DM, editors. Inflammation and immunology in chronic inflammatory periodontal disease. Northwood : Science Reviews Limited, 107-126.
33.
Hopps AM, Prout RES (1972). Identification of tissue and bacterial hyaluronidase in human saliva. J Periodont Res7:236-241.
34.
Hopps RM, Sismey-Durrant HJ (1991 ). Mechanisms of alveolar bone loss in periodontal disease. In: Hamada S, Holt SC, McGhee JR , editors.
35.
Periodontal disease: Pathogens and host immune response. Tokyo: Quintessence, 307-320.
36.
Ishikawa I., Cimasoni G., Ahmad-Zadeh C. (1972). Possible role of lysosomal enzymes in the pathogenesis of periodontitis. A study on cathepsin D in human gingival fluid. Arch Oral Biol17:111-117.
37.
Johnson NW (1991). Crevicular fluid-based diagnostic tests. Curr Opin Dent1:52-65.
38.
Kinane DF, Winstanley FP, Adonogianaki E., Moughal NA (1992). Bioassay of interleukin 1 (IL-1) in human gingival crevicular fluid during experimental gingivitis. Arch Oral Biol37:153-156.
39.
Kowashi Y., Jaccard F., Cimasoni G. (1979). Increase of free collagenase and neutral protease activities in the gingival crevice during experimental gingivitis in man. Arch Oral Biol24:645-650.
40.
Kunimatsu K., Yamamoto K., Ichimaru E., Kato Y., Kato I. ( 1990). Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J Periodont Res25:69-73.
41.
Lamster IB (1991). Host-derived enzyme activities in gingival crevicular fluid as markers of periodontal disease susceptibility and activity: historical perspective, biological significance and clinical implications. In: Johnson NW, editor. Risk markers for oral diseases. Periodontal diseases; markers of disease susceptibility and activity . Cambridge: Cambridge University Press, 227-312.
42.
Lamster IB, Oshrain RL, Harper DS, Celenti RS, Hovliaras CA, Gordon JM (1988). Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis: 6-months results. J Periodontol59:516-523.
43.
Last KS, Howell R., Cawood J., Embery G. (1991). Monitoring of Tubingen endosseous dental implants by glycosaminoglycan analysis of gingival crevicular fluid. Int J Oral Maxillofac Implants6:42-49.
44.
Makinen KK, Syed SA, Makinen PL, Loesche WJ (1987). Dominance of aminopeptidase in the human oral bacterium, Treponema denticola ATCC 35405. CurrMicrobiol14 :341-346.
45.
Marsh PD (1991). Do bacterial markers exist in subgingival plaque for predicting periodontal disease susceptibility? In: Johnson NW, editor. Risk markers for oral diseases. Periodontal diseases; markers of disease susceptibility and activity. Vol. 3. Cambridge: Cambridge University Press, 365-388.
46.
Masada MP, Persson R., Kenney JS, Lee SW, Page RC, Allison AC (1990). Measurement of interleukin-1 alpha and-1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res25:156-163.
47.
Meikle MC, McFarlane CG, Newman HN, Reynolds JJ (1992). Cytokines and connective tissue degradation in chronic inflammatory periodontal disease. In: Newman HN, Williams DM. Inflammation and immunology in chronic inflammatory periodontal disease. Proceedings of a symposium under the auspices of the British Inflammation Research Association. Northwood: Science Reviews Limited, 87-106.
48.
Meng HX, James IT, Skingle L., Johnson NW, Thompson PW (1991). Collagen cross-links in human gingival crevicular fluid (abstract). J Dent Res70:714.
49.
Modeer T., Twetman S. (1979). Lysozyme activity in saliva from children with various degrees of gingivitis. SwedDent
50.
J 3:63-67.
51.
Moore WEC, Cato EP, Holdeman LV (1981). Butyric acid bacteria in periodontal disease (abstract) . J Dent Res60:414.
52.
Narayanan AS, Engel LD, Page RC ( 1983). The effect of chronic inflammation on the composition of collagen types in human connective tissues. Collagen Rel Res3:323-334.
53.
Offenbacher S., Farr DH, Goodson JM (1981). Measurement of prostaglandin E in crevicular fluid . J Clin Periodontol8:359-367.
54.
Offenbacher S., Odle BM, Gray RC, Van Dyke TE (1984). Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult andjuvenile periodontitis patients . J Periodont Res19:1-3.
55.
Offenbacher S., Soskolne WA, Collins JG (1991). Prostaglandins and other eicosanoids in gingival crevicular fluid as markers of periodontal disease activity. In: Johnson NW, editor. Risk markers for oral diseases. Periodontal diseases; markers of disease susceptibility and activity. Vol. 3. Cambridge: Cambridge University Press, 313-337.
56.
Palcanis KG, Larjava IK, Wells BR, Suggs KA, Landis JR, Chadwick DE, et al. (1992). Elastase as an indicator of periodontal disease progression. J Periodontol63:237-242.
57.
Patters MR, Niekrash CE, Lang NP ( 1985). Assessment of complement cleavage in gingival fluid during experimental gingivitis in humans (abstract). J Dent Res64:360.
58.
Patters MR, Niekrash CE, Lang NP ( 1989). Assessment of complement cleavage in gingival fluid during experimental gingivitis in man. J Clin Periodontol16:33-37.
59.
Persson GR, DeRouen TA, Page RC ( 1990). Relationship between gingival crevicular fluid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients. J Periodont Res25:81-87.
60.
Reinhardt RA, McDonald TL, Bolton RW, Dubois LM, Kaldahl WB (1989). IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol60:44-50.
61.
Rossomando EF, Kennedy JE, Hadjimichael J. (1990). Tumor necrosis factor alpha in gingival crevicular fluid as apossible indicator of periodontal disease in humans. Arch Oral Biol35:431-434.
62.
Schenck K., Porter S., Tollefsen T., Johansen J., Scully S. (1989). Serum levels of antibodies against Actinobacillus actinomycetemcomitans in various forms of human periodontitis. Acta Odontol Scand47:271-277.
63.
Schiøtt CR, Loe H. (1970). The origin and variation in number of leucocytes in the human saliva. J Periodont Res5:36-41.
64.
Shah HN, Gharbia SE (1992). Microbial factors in the etiology of chronic inflammatory periodontal disease. In: Newman HN, Williams DM, editors. Inflammation and immunology in chronic inflammatory periodontal disease. Proceedings of a symposium under the auspices of the British Inflammation Research Association . Northwood: Science Reviews Limited , 1-32.
65.
Simon B., Goldman H., Ruben M., Baker E. (1971). The role of endotoxins in periodontal disease. III. Correlation of the quantity of endotoxin in human gingival exudate with the histologic degree of inflammation. J Periodontol42 :210-216.
66.
Sismey-Durrant HJ, Atkinson SJ, Hopps RM, Heath JK ( 1989). The effect of lipopolysaccharide from Bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase releases. Calcif Tissue Int44:361-363.
67.
Skapski H., Lehner T. (1976). A crevicular washing method for investigating immune components of crevicular fluid in man. J Periodont Res11:19-24.
68.
Smith QT, Hinrichs JE, MelnykRS (1986). Gingival crevicular fluid myeloperoxidase at periodontitis sites. J Periodont Res21:45-55.
69.
Solis-Gaffar MC, Rustogi KN, Gaffar A. (1980). Hydrogen sulphide production from gingival crevicular fluid. J Periodontol51:606-607.
70.
Stashenko P., Jandinski JJ, Fujiyoshi P., Rynar J., Socransky SS (1991). Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol62:504-509.
Tew JG, Marshall DR, Ranney RR (1985). Depressed and elevated levels of antibody specific for periodontitis associated bacteria in crevicular fluid (abstract). J Dent Res64:355.
73.
Thurre C., Robert M., Cimasoni G., Baehni P. (1984). Gingival sulcular leucocytes in periodontitis and in experimental gingivitis in humans. J Periodont Res19:457-468.
74.
Tzamouranis A., Matthys J., Ishikawa I., Cimasoni G. (1977). Increase in extracellular cathepsin D activity in gingival washings during experimental gingivitis in man. Arch Oral Biol22:375-378.
75.
Uitto V.-J, Chan ECS, Chin Quee T. (1986). Initial characterization of neutral proteinases from oral spirochetes. J Periodont Res21:95-100.
76.
Villela B., Birkedal-Hansen H. (1985). Collagenolytic activity as an indicator of periodontal disease activity (abstract). J Dent Res64:374.
77.
Villela B., Cogen RB, Bartolucci AA, Birkedal-Hansen H. (1987). Crevicular fluid collagenase activity in health, gingivitis, chronic periodontitis and localized juvenile periodontitis. J Periodont Res22:209-211.
78.
Vratsanos SM, Mandel ID (1985). Polyamines of dental plaque in caries-resistant versus caries-susceptible adults. J Dent Res64:422-424.
79.
Waddington RJ (1991). The characterization of human alveolar bone proteoglycan and their role as markers of active tissue destruction (abstract). J Dent Res70:383.
80.
Waddington RJ, Embery G. ( 1991 ). Structural characterization of human alveolar bone proteoglycans. Arch Oral Biol36:859-866.
81.
Wilton JMA, Bampton JIM (1992). Inflammatory events in the gingival crevice. In: Newman HN, Williams DM, editors. Inflammation and immunology in chronic inflammatory periodontal disease. Proceedings of a symposium under the auspices of the British Inflammation Research Association . Northwood: Science Reviews Limited , 33-68.
